Jake Harper
Jake is a reporter with Side Effects and WFYI in Indianapolis. He decided to pursue radio journalism while volunteering at a community station in Madison, WI, and soon after began an internship with NPR's State of the Re:Union. Jake has received a first place award from the Milwaukee Press Club and he was a finalist in KCRW's 24-Hour Radio Race. In his spare time, he runs and tries to perfect his pizza crust recipe.
-
Undocumented patients with kidney disease often can't get treatment unless they are in a state of emergency — this bothers clinicians who want to treat all patients equally.
-
As the nation grapples with a crisis of opioid addiction, a medical device called the Bridge is being touted as a way to help people through the symptoms of withdrawal. Does it work?
-
The U.S. surgeon general has recommended that naloxone, the opioid overdose reversal drug, be widely available to consumers. But there are several barriers to consumers' ability to acquire it.
-
Standards for how to investigate and report on overdoses vary widely across states and counties. As a result, opioid overdose deaths often go overlooked in the data reported to the federal government.
-
Indiana is one of the states poised to get permission to require Medicaid recipients to work. Advocates say work requirements may be good politics but they're bad policy.
-
Researchers found two addiction medicines equally effective once treatment started. But there are fundamental differences in the way treatment begins with each drug, complicating the interpretation.
-
The pharmaceutical company Alkermes is trying to increase the number of people taking Vivitrol for their opioid addiction by marketing the drug to judges, who have the power to influence treatment.
-
The maker of one medical treatment for opioid abuse has successfully lobbied statehouses around the country to pass policies that tilt addiction treatment practices in favor of the company's drug.
-
Nearly 700 experts signed a letter to HHS Secretary Tom Price asking that he correct remarks in which he called medication-assisted treatment for addiction "substituting one opioid for another."
-
Indiana's health program for low-income people is experimental, and needs federal approval to continue. The state says its program is working, but some claims lack much-needed context.